Skip to content

Home
About Us
- Board of Directors
- Management Team
Technology
News/Resources
Investor Centre
Contacts

Half-year Report 31 December 2023

27 February 2024 by Audrey Thomson

Half-year Report 31 December 2023

Categories 2024, ASX Announcements, Half-year reports

R&D Tax Incentive

Positive Outcomes in BIT225 Phase 2 Clinical Trial in HIV-1 (BIT225-010)

© Biotron Limited 2016 ABN 60 086 399 144 Site updated 6 January 2025 Legal Notices and Privacy